Lithium Americas Corp vs Eli Lilly And Co — how do they compare? Lithium Americas Corp trades at $3.27 (market cap $1.18B), while Eli Lilly And Co trades at $1,213.85 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 915.3× Lithium Americas Corp's market cap, and Eli Lilly And Co pays a 0.57% dividend while Lithium Americas Corp pays none. Which is the better fit depends on your goals.
| LAC | LLY | |
|---|---|---|
Market Cap | $1.18B | $1.08T |
Sector | Basic Materials | Health |
52-Week High | $10.05 | $1.24K |
52-Week Low | $2.71 | $639.43 |
Enterprise Value | $1.29B | $1.13T |
Dividend Yield | — | 0.57% |
Signals from Pluang's Aura AI — not financial advice
Lithium Americas (LAC) trades at $3.23, up 6.95% today, but remains in a bearish technical trend with negative profitability metrics. The company reported a net loss of $122.09 million for 2025 and continues to burn cash from operations. Recent news highlights $175 million financing for Thacker Pass construction, providing balance sheet support amid ongoing capital expenditures exceeding $900 million annually.
While analyst consensus leans positive with no sell ratings, significant execution risks persist as LAC navigates peak construction phase. The stock faces headwinds from negative ROE (-11.35%) and cash burn, though strategic positioning in lithium development offers long-term potential if project timelines and funding are successfully managed.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →